Completed PHASE2 INTERVENTIONAL NCT00015132

Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9

CREST-II: Tiagabine, Sertraline, or Donepezil vs. Unmatched Placebo

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions Sertraline

Updated 5 times since 2017 Last updated: Jan 11, 2017 Started: Mar 31, 1999 Primary completion: Sep 30, 2000 Completion: Nov 30, 2000

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Cocaine-Related Disorders and is currently completed. National Institute on Drug Abuse (NIDA) leads this study, which shows 5 recorded versions since 1999 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)

Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cincinnati, United States